跳到正文
OncoDaily RT· @OncoDailyRT · X·· 18 小时前评分70

SANO

正文 · 原文

SANO 5-year results at #ESMO2026:

Overall survival was 50% with active surveillance vs 54% with surgery after complete response to neoadjuvant CRT.

Distant metastases were higher (46% vs 29%), while 43% avoided non-beneficial esophagectomy.

https://oncodaily.com/oncolibrary/radiotherapy/sano-trial

@myESMO

23 浏览 · 1 赞 · 0 转发 · 0 回复

会议摘要
LBA78按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上

Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: Long-term results of a cluster-randomised controlled trial (SANO)

https://esmocongress.esmo.org

来源:OncoDaily RT · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org